{"title":"盘点-波兰药用大麻合法化七年后:用户的观点。","authors":"Greg Los","doi":"10.1080/10826084.2024.2434683","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>It has been seven years since Poland legalized medical cannabis. Doctors in Poland are allowed to prescribe medical cannabis, which can be then obtained <i>via</i> pharmacies. However, no evaluation has been produced to explore what this policy has achieved.</p><p><strong>Method: </strong>This article uses online surveys (<i>N</i> = 571) and qualitative interviews to explore what Polish cannabis users think of the current system.</p><p><strong>Results: </strong>Most users - medical and recreational - think that it is currently easy to obtain a prescription for medical cannabis in Poland, and medical cannabis from a pharmacy. The users seem to have a clear preference for cannabis clinics as a source of prescriptions for medical cannabis over traditional doctors. Doctors in cannabis clinics seem much more inclined to prescribe medical cannabis. Many respondents, however, agree that the current system remains too expensive, and many users also raise concerns about the quality of cannabis available from pharmacies and strain variation.</p><p><strong>Conclusion: </strong>This article shows the emergence of a unique drug policy/model. The access to medical cannabis has improved significantly since the early stages of the policy. Notably - contrary to the wishes of the policymakers who wanted to create a \"strict\" medical model with the use of pharmacies, both - medical and recreational users seem to be benefiting from the current system.</p>","PeriodicalId":22088,"journal":{"name":"Substance Use & Misuse","volume":" ","pages":"522-530"},"PeriodicalIF":1.8000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Taking Stock - Legalization of Polish Medicinal Cannabis Seven Years Later: Users' Perspectives.\",\"authors\":\"Greg Los\",\"doi\":\"10.1080/10826084.2024.2434683\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>It has been seven years since Poland legalized medical cannabis. Doctors in Poland are allowed to prescribe medical cannabis, which can be then obtained <i>via</i> pharmacies. However, no evaluation has been produced to explore what this policy has achieved.</p><p><strong>Method: </strong>This article uses online surveys (<i>N</i> = 571) and qualitative interviews to explore what Polish cannabis users think of the current system.</p><p><strong>Results: </strong>Most users - medical and recreational - think that it is currently easy to obtain a prescription for medical cannabis in Poland, and medical cannabis from a pharmacy. The users seem to have a clear preference for cannabis clinics as a source of prescriptions for medical cannabis over traditional doctors. Doctors in cannabis clinics seem much more inclined to prescribe medical cannabis. Many respondents, however, agree that the current system remains too expensive, and many users also raise concerns about the quality of cannabis available from pharmacies and strain variation.</p><p><strong>Conclusion: </strong>This article shows the emergence of a unique drug policy/model. The access to medical cannabis has improved significantly since the early stages of the policy. Notably - contrary to the wishes of the policymakers who wanted to create a \\\"strict\\\" medical model with the use of pharmacies, both - medical and recreational users seem to be benefiting from the current system.</p>\",\"PeriodicalId\":22088,\"journal\":{\"name\":\"Substance Use & Misuse\",\"volume\":\" \",\"pages\":\"522-530\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Substance Use & Misuse\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/10826084.2024.2434683\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/11/29 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Substance Use & Misuse","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10826084.2024.2434683","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/29 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PSYCHIATRY","Score":null,"Total":0}
Taking Stock - Legalization of Polish Medicinal Cannabis Seven Years Later: Users' Perspectives.
Background: It has been seven years since Poland legalized medical cannabis. Doctors in Poland are allowed to prescribe medical cannabis, which can be then obtained via pharmacies. However, no evaluation has been produced to explore what this policy has achieved.
Method: This article uses online surveys (N = 571) and qualitative interviews to explore what Polish cannabis users think of the current system.
Results: Most users - medical and recreational - think that it is currently easy to obtain a prescription for medical cannabis in Poland, and medical cannabis from a pharmacy. The users seem to have a clear preference for cannabis clinics as a source of prescriptions for medical cannabis over traditional doctors. Doctors in cannabis clinics seem much more inclined to prescribe medical cannabis. Many respondents, however, agree that the current system remains too expensive, and many users also raise concerns about the quality of cannabis available from pharmacies and strain variation.
Conclusion: This article shows the emergence of a unique drug policy/model. The access to medical cannabis has improved significantly since the early stages of the policy. Notably - contrary to the wishes of the policymakers who wanted to create a "strict" medical model with the use of pharmacies, both - medical and recreational users seem to be benefiting from the current system.
期刊介绍:
For over 50 years, Substance Use & Misuse (formerly The International Journal of the Addictions) has provided a unique international multidisciplinary venue for the exchange of original research, theories, policy analyses, and unresolved issues concerning substance use and misuse (licit and illicit drugs, alcohol, nicotine, and eating disorders). Guest editors for special issues devoted to single topics of current concern are invited.
Topics covered include:
Clinical trials and clinical research (treatment and prevention of substance misuse and related infectious diseases)
Epidemiology of substance misuse and related infectious diseases
Social pharmacology
Meta-analyses and systematic reviews
Translation of scientific findings to real world clinical and other settings
Adolescent and student-focused research
State of the art quantitative and qualitative research
Policy analyses
Negative results and intervention failures that are instructive
Validity studies of instruments, scales, and tests that are generalizable
Critiques and essays on unresolved issues
Authors can choose to publish gold open access in this journal.